32 years' experience of peritoneal dialysis-related peritonitis in a university hospital. - Wikidata - awgldk - TriplyDB

32 years' experience of peritoneal dialysis-related peritonitis in a university hospital.

32 years' experience of peritoneal dialysis-related peritonitis in a university hospital.

http://www.wikidata.org/entity/Q37669414

about

Peritoneal dialysis: update on patient survival.Microbiological Surveillance of Peritoneal Dialysis Associated Peritonitis: Antimicrobial Susceptibility Profiles of a Referral Center in GERMANY over 32 Years.Deciphering the Contribution of Biofilm to the Pathogenesis of Peritoneal Dialysis Infections: Characterization and Microbial Behaviour on Dialysis Fluids.Prognostic impact of peritonitis in hemodialysis patients: A national-wide longitudinal study in Taiwan.Infection-related hospitalizations over 30 years of follow-up in patients starting renal replacement therapy at pediatric age.Peritonitis rates of the past thirty years: from improvement to stagnation Evaluating the benefits of home-based peritoneal dialysis.Long-Term Exit-Site Gentamicin Prophylaxis and Gentamicin Resistance in a Peritoneal Dialysis Program.The Association Between Glucose Exposure and the Risk of Peritonitis in Peritoneal Dialysis Patients.A contemporary approach to the prevention of peritoneal dialysis-related peritonitis in children: the role of improvement science.Compatibility of fosfomycin with different commercial peritoneal dialysis solutions.Influence of Different Peritoneal Dialysis Fluids on the In Vitro Activity of Cefepime, Ciprofloxacin, Ertapenem, Meropenem and Tobramycin Against Escherichia Coli.The influence of different peritoneal dialysis fluids on the in vitro activity of ampicillin, daptomycin, and linezolid against Enterococcus faecalis.Comparison of peritonitis rates and patient survival in automated and continuous ambulatory peritoneal dialysis: a 10-year single center experience.33 Years of Peritoneal Dialysis-Associated Peritonitis: A Single-Center Study in Japan.Influence of different peritoneal dialysis fluids on the in vitro activity of fosfomycin against Escherichia coli, Staphylococcus aureus, Staphylococcus epidermidis, and Pseudomonas aeruginosa.Age-Related Differences of Organism-Specific Peritonitis Rates: A Single-Center Experience.Prevalence of peritonitis and mortality in patients treated with continuous ambulatory peritoneal dialysis (CAPD) in Africa: a protocol for a systematic review and meta-analysis.

P2860

Q33786287-0AB9D82F-AB6F-4E46-867F-6EBA23B10D90 Q35787561-EF4DD3B4-1796-4901-8078-7AA2F1A2879F Q36059841-1BBF444D-DFC3-48AD-9589-DBF3B4A03160 Q36310642-DCAD2334-19A7-40C5-9A47-BC977FC40A67 Q36400328-BFD8FBD9-5890-4A34-BDEE-01DDAC8D590D Q37669407-610A10FB-40F5-43BD-BF1E-A3185F290558 Q38288242-98F98389-3C68-4C91-9EB4-955BD6A60805 Q38658410-5B06314C-5DF3-453F-B9CB-1129010615B7 Q38798159-42EB907D-DF8C-4970-AE4D-B33375ADEC45 Q38984936-9D48BCFE-873D-48D5-A538-497F98D26303 Q39153521-EB790C82-43D2-468E-B581-0820ECF42258 Q39153527-C01C41FC-5C63-4998-8769-6B91D1762AC9 Q39153535-7EA85961-462F-412F-AB86-376D788FABA5 Q39584517-E8E739F4-7F6A-4D89-9306-445A1BE2174C Q40312576-82101CDE-0ECB-4CD9-86E7-B06C1712620E Q51739440-3170176A-3FA1-4DC7-937C-F13D90E620FC Q54543009-052A0E9B-6371-47A7-A3BD-79595C0FFE09 Q55128074-5D5981EE-9956-40A2-A650-30220FF693D5

P2860

32 years' experience of peritoneal dialysis-related peritonitis in a university hospital.

http://www.wikidata.org/entity/Q37669414

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on March 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

32 years' experience of peritoneal dialysis-related peritonitis in a university hospital.

@en

32 years' experience of peritoneal dialysis-related peritonitis in a university hospital.

@nl

type

label

32 years' experience of peritoneal dialysis-related peritonitis in a university hospital.

@en

32 years' experience of peritoneal dialysis-related peritonitis in a university hospital.

@nl

prefLabel

32 years' experience of peritoneal dialysis-related peritonitis in a university hospital.

@en

32 years' experience of peritoneal dialysis-related peritonitis in a university hospital.

@nl

P1433

Q37669414-9344BFE3-F0A0-4492-AEDC-B48BEFFB24AA

P1476

Q37669414-4EB7651A-7696-4FC6-9591-BC1BD0F1797A

P2093

Q37669414-00781108-59F7-455A-B5AC-CB4D5608A835

Q37669414-488F9CA6-CD2B-4018-91B7-328AC3778735

Q37669414-5121F8CB-067F-4B79-8424-3C38D6C29E77

P2860

Q37669414-0CD6B0DF-FDF3-46B7-88D2-C7BFF6B73685

Q37669414-1537F03D-65F5-4C9A-AEAE-0CD3D080597F

Q37669414-1846CD83-8410-4A2A-99EE-9A1F5CED8095

Q37669414-1F24B44F-DA77-4372-A7F0-7BA1D632CE62

Q37669414-234CF7D8-088D-4A7E-9020-A8AD75C8047A

Q37669414-28D225FE-8424-40C5-9EA0-79277B1FB5F5

Q37669414-302B09D3-1C6E-4868-B5D8-AFC2608018B9

Q37669414-547AF540-4937-457C-9D5B-86D3D9124146

Q37669414-5482A7D6-6B69-4859-B1EC-920AF38B534B

Q37669414-631E2D6B-AB92-49BD-B525-82B4B7B6A029

P304

Q37669414-6BB25611-C6E7-4C4E-ADBE-AE7B904FA1AE

P31

Q37669414-B9798EE2-908E-4C55-A94A-9025493EA484

P356

Q37669414-5A7DD32A-329F-4350-A0B6-10A87A2192B2

P433

Q37669414-B0816802-C5B5-469C-A742-1C738AD3E666

P478

Q37669414-876F9111-D4BB-4C5E-B1D5-237A5C801E9F

P577

Q37669414-8834F2F5-4568-45D5-B495-FC28973FCD2C

P698

Q37669414-3E4D0079-6432-48C3-B6C3-717BE38A030B

P921

Q37669414-968833FE-1EE2-4C27-90A2-EC0F0F7C19BC

P932

Q37669414-094B5796-6D3C-4980-B150-CC46751F5BEC

P356

P1433

Peritoneal Dialysis International

P1476

32 years' experience of peritoneal dialysis-related peritonitis in a university hospital.

@en

P2093

Dirk G Struijk

http://www.w3.org/2001/XMLSchema#string

Raymond T Krediet

http://www.w3.org/2001/XMLSchema#string

Sadie van Esch

http://www.w3.org/2001/XMLSchema#string

P2860

Antimicrobial agents for preventing peritonitis in peritoneal dialysis patients

A comparison of peritonitis rates from the United States Renal Data System database: CAPD versus continuous cycling peritoneal dialysis patients.

Double bag or Y-set versus standard transfer systems for continuous ambulatory peritoneal dialysis in end-stage renal disease.

Relevance of C-reactive protein levels in peritoneal dialysis patients.

Preventing bacterial infections and antimicrobial resistance in dialysis patients.

A 12-month review of peritoneal dialysis-related peritonitis in Western Australia: is empiric vancomycin still indicated for some patients?

Changes in causative organisms and their antimicrobial susceptibilities in CAPD peritonitis: a single center's experience over one decade.

Geographic and educational factors and risk of the first peritonitis episode in Brazilian Peritoneal Dialysis study (BRAZPD) patients.

Recent peritonitis associates with mortality among patients treated with peritoneal dialysis.

Predictors of peritonitis in patients on peritoneal dialysis: results of a large, prospective Canadian database.

P304

162-170

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3747/PDI.2013.00275

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P577

2014-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24584620

http://www.w3.org/2001/XMLSchema#string

P921

P932

3968101

http://www.w3.org/2001/XMLSchema#string